K. Schmiegelow

K. Schmiegelow

Clinical Professor

Member of:

  • Paediatrics


  1. Published

    Treatment-related mortality among children with cancer in Denmark during 2001-2021

    Sørensen, M. C. L., Andersen, M. M., Rostgaard, K., Schmiegelow, Kjeld, Mikkelsen, T. S., Wehner, P. S., Olsen, M., Søegaard, S. H. & Hjalgrim, L. L., 2024, In: Acta oncologica (Stockholm, Sweden). 63, p. 294-302 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Treatment-related Myelodysplastic Syndrome in a Child With Acute Myeloid Leukemia and TPMT Heterozygosity

    Stensman, L. M., Kjeldsen, E., Nersting, J., Schmiegelow, Kjeld & Hasle, H., 2015, In: Journal of Pediatric Hematology/Oncology. 37, 4, p. e242–e244 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95

    Dörffel, W., Rühl, U., Lüders, H., Claviez, A., Albrecht, M., Bökkerink, J., Holte, H., Karlen, J., Mann, G., Marciniak, H., Niggli, F., Schmiegelow, Kjeld, Schwarze, E., Pötter, R., Wickmann, L. & Schellong, G., 2013, In: Journal of Clinical Oncology. 31, 12, p. 1562-1568 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia

    Toft, N., Birgens, H., Abrahamsson, J., Griškevičius, L., Hallböök, H., Heyman, M., Klausen, T. W., Jónsson, Ó. G., Palk, K., Pruunsild, K., Quist-Paulsen, P., Vaitkeviciene, G., Vettenranta, K., Asberg, A., Helt, L. R., Frandsen, T. & Schmiegelow, Kjeld, Feb 2016, In: European Journal of Haematology. 96, 2, p. 160-169 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

    Rank, C. U., Toft, N., Tuckuviene, R., Grell, K., Nielsen, O. J., Frandsen, T. L., Marquart, H. V. H., Albertsen, B. K., Tedgård, U., Hallböök, H., Ruud, E., Jarvis, K. B., Quist-Paulsen, P., Huttunen, P., Wartiovaara-Kautto, U., Jónsson, Ó. G., Trakymiene, S. S., Griškevičius, L., Saks, K., Punab, M. & 1 others, Schmiegelow, Kjeld, 2018, In: Blood. 131, 22, p. 2475-2484 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

    Schmiegelow, Kjeld, Forestier, E., Kristinsson, J., Söderhäll, S., Vettenranta, K., Weinshilboum, R., Wesenberg, F. & Nordic Society of Paediatric Haematology and Oncology, N. S. O. P. H. A. O., 2008, In: Leukemia. 23, 3, p. 557-64 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol

    Toksvang, L. N., Als-Nielsen, B., Bacon, C., Bertasiute, R., Duarte, X., Escherich, G., Helgadottir, E. A., Johannsdottir, I. R., Jónsson, Ó. G., Kozlowski, P., Langenskjöld, C., Lepik, K., Niinimäki, R., Overgaard, U. M., Punab, M., Räty, R., Segers, H., van der Sluis, I., Smith, O. P., Strullu, M. & 4 others, Vaitkevičienė, G., Wik, H. S., Heyman, M. & Schmiegelow, Kjeld, 2022, In: BMC Cancer. 22, 19 p., 483.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade

    Nazerai, L., Willis, S. C., Yankilevich, P., Di Leo, L., Bosisio, F. M., Frias, A., Bertolotto, C., Nersting, J., Thastrup, M., Buus, Søren, Thomsen, Allan Randrup, Nielsen, M., Rohrberg, K. S., Schmiegelow, Kjeld & de Zio, Daniela, 2023, In: OncoImmunology. 12, 1, 16 p., 2158610.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Therapeutic drug monitoring of imatinib: how far are we in the leukemia setting?

    Rasmussen, A. S. B., Andersen, C. L., Weimann, A., Yang, Tianwu, Tron, C., Gandemer, V., Dalhoff, Kim, Rank, C. U. & Schmiegelow, Kjeld, 2024, In: Expert Review of Clinical Pharmacology. 17, 3, p. 225-234

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols

    Öfverholm, I., Rezayee, F., Heyman, M., Harila, A., Arvidsson, L., Schmiegelow, Kjeld, Norén-Nyström, U. & Barbany, G., 2023, In: British Journal of Haematology. 202, 2, p. 384-392 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...38 Next

ID: 8780